Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.032 | 0.7 |
mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.019 | 0.7 |
mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.7 |
mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | -0.022 | 0.7 |
mRNA | IU1 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | lapatinib | UHNBreast | pan-cancer | AAC | 0.12 | 0.7 |
mRNA | carboplatin:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |